These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 19029828
1. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d. Forget A, Ayrault O, den Besten W, Kuo ML, Sherr CJ, Roussel MF. Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828 [Abstract] [Full Text] [Related]
2. p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis. Buchold GM, Magyar PL, Arumugam R, Lee MM, O'Brien DA. Mol Reprod Dev; 2007 Aug; 74(8):997-1007. PubMed ID: 17342741 [Abstract] [Full Text] [Related]
3. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d). Zindy F, den Besten W, Chen B, Rehg JE, Latres E, Barbacid M, Pollard JW, Sherr CJ, Cohen PE, Roussel MF. Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627 [Abstract] [Full Text] [Related]
4. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a. Baumgartner R, Fernandez-Catalan C, Winoto A, Huber R, Engh RA, Holak TA. Structure; 1998 Oct 15; 6(10):1279-90. PubMed ID: 9782052 [Abstract] [Full Text] [Related]
5. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. Kovalev GI, Franklin DS, Coffield VM, Xiong Y, Su L. J Immunol; 2001 Sep 15; 167(6):3285-92. PubMed ID: 11544316 [Abstract] [Full Text] [Related]
6. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ. Mol Cell Biol; 1995 May 15; 15(5):2672-81. PubMed ID: 7739547 [Abstract] [Full Text] [Related]
7. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths. Renner C, Baumgartner R, Noegel AA, Holak TA. J Mol Biol; 1998 May 15; 283(1):221-9. PubMed ID: 9761685 [Abstract] [Full Text] [Related]
8. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Ramsey MR, Krishnamurthy J, Pei XH, Torrice C, Lin W, Carrasco DR, Ligon KL, Xiong Y, Sharpless NE. Cancer Res; 2007 May 15; 67(10):4732-41. PubMed ID: 17510401 [Abstract] [Full Text] [Related]
11. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. Thullberg M, Bartkova J, Khan S, Hansen K, Rönnstrand L, Lukas J, Strauss M, Bartek J. FEBS Lett; 2000 Mar 24; 470(2):161-6. PubMed ID: 10734227 [Abstract] [Full Text] [Related]
12. Expression of p18(INK4C) is down-regulated in human pituitary adenomas. Hossain MG, Iwata T, Mizusawa N, Qian ZR, Shima SW, Okutsu T, Yamada S, Sano T, Yoshimoto K. Endocr Pathol; 2009 Mar 24; 20(2):114-21. PubMed ID: 19401813 [Abstract] [Full Text] [Related]
13. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4. Guan KL, Jenkins CW, Li Y, O'Keefe CL, Noh S, Wu X, Zariwala M, Matera AG, Xiong Y. Mol Biol Cell; 1996 Jan 24; 7(1):57-70. PubMed ID: 8741839 [Abstract] [Full Text] [Related]
20. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors. Zhang S, Tang Q, Xu F, Xue Y, Zhen Z, Deng Y, Liu M, Chen J, Liu S, Qiu M, Liao Z, Li Z, Luo D, Shi F, Zheng Y, Bi F. Mol Cancer Res; 2009 Apr 24; 7(4):570-80. PubMed ID: 19372585 [Abstract] [Full Text] [Related] Page: [Next] [New Search]